Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver
暂无分享,去创建一个
T. Dawson | D. Kleiner | Nae-Yuh Wang | M. Iijima | M. Aghajan | A. Rosenberg | T. Yanagawa | H. Sesaki | Tatsuya Yamada | Daisuke Murata | Andrew F. Powers | Moshe Levi | R. Anders | J. Hamilton | Jeffrey Kaplan
[1] R. Green,et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet , 2008 .
[2] M. Wood,et al. Antisense oligonucleotides: the next frontier for treatment of neurological disorders , 2018, Nature Reviews Neurology.
[3] P. Reddy,et al. Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage , 2012, The Journal of cell biology.
[4] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.
[5] P. Reddy,et al. Mitochondrial division and fusion in metabolism. , 2015, Current opinion in cell biology.
[6] B. Monia,et al. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. , 1997, Molecular pharmacology.
[7] A. J. Goodell,et al. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model , 2017, BMJ Open.
[8] D. Kleiner. Histopathology, grading and staging of nonalcoholic fatty liver disease. , 2018, Minerva gastroenterologica e dietologica.
[9] C. F. Bennett,et al. Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents , 2003, The Journal of Biological Chemistry.
[10] Yoshihisa Takahashi,et al. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2014, World journal of gastroenterology.
[11] R. E. Pitas,et al. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞ Published, JLR Papers in Press, July 8, 2006. , 2006, Journal of Lipid Research.
[12] M. Kwak,et al. Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration , 2010, Science Signaling.
[13] L. Vonghia,et al. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide , 2017, Nutrients.
[14] C. Byrne,et al. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus , 2018, Nature Reviews Endocrinology.
[15] M. Magnuson,et al. Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.
[16] T. Kensler,et al. The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice , 2009, The Journal of cell biology.
[17] Y. Adachi,et al. Phosphatidic Acid and Cardiolipin Coordinate Mitochondrial Dynamics. , 2018, Trends in cell biology.
[18] T. Dawson,et al. SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy , 2019, Autophagy.
[19] T. P. Prakash,et al. Synthesis and biophysical evaluation of 2',4'-constrained 2'O-methoxyethyl and 2',4'-constrained 2'O-ethyl nucleic acid analogues. , 2010, The Journal of organic chemistry.
[20] M. Hofker,et al. LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease , 2012, PloS one.
[21] D. Corey,et al. Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs , 2017, Nucleic acids research.
[22] Aijaz Ahmed,et al. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[23] G. Jacquemin. [Nonalcoholic steatohepatitis: a review]. , 2003, Revue medicale de Liege.
[24] Arwen W. Gao,et al. Mfn1 Deficiency in the Liver Protects Against Diet-Induced Insulin Resistance and Enhances the Hypoglycemic Effect of Metformin , 2016, Diabetes.
[25] A. Feldstein,et al. Triggering and resolution of inflammation in NASH , 2018, Nature Reviews Gastroenterology & Hepatology.
[26] R. Huganir,et al. Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease. , 2018, Cell metabolism.